Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2429)
All Articles published online
|
Dec 14, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(46): 7117-7121 [PMID: 19084920 DOI: 10.3748/wjg.14.7117] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v14/i46/7117.htm |
| Number | Citing Articles |
| 1 |
Erkin Oztas, Ufuk Baris Kuzu, Neslihan Inci Zengin, Ismail Hakki Kalkan, Fatih Saygili, Hakan Yildiz, Huseyin Tugrul Celik, Meral Akdogan, Mesut Yalin Kilic, Aydin Seref Koksal, Bulent Odemis, Nuretdin Suna, Ertugrul Kayacetin. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?. Medicine 2015; 94(47): e1889 doi: 10.1097/MD.0000000000001889
|
| 2 |
Da-Wu Zeng, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World Journal of Gastroenterology 2016; 22(43): 9586-9594 doi: 10.3748/wjg.v22.i43.9586
|
| 3 |
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
|
| 4 |
Danan Wang, Qinghui Wang, Fengping Shan, Beixing Liu, Changlong Lu. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-251
|
| 5 |
Wenwen Jin, Zhonghua Lin, Yongning Xin, Xiangjun Jiang, Quanjiang Dong, Shiying Xuan. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-14
|
| 6 |
Giada Sebastiani. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World Journal of Gastroenterology 2009; 15(18): 2190-2203 doi: 10.3748/wjg.15.2190
|
| 7 |
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by
Noninvasive Biochemical Markers in
Egyptian Patients with Chronic Hepatitis B. Euroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
|
| 8 |
Da-Wu Zeng, Jing Dong, Yu-Rui Liu, Jia-Ji Jiang, Yue-Yong Zhu. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(29): 6663-6672 doi: 10.3748/wjg.v22.i29.6663
|
| 9 |
A.S.F. Lok. Hepatitis B: Liver fibrosis and hepatocellular carcinoma. Gastroentérologie Clinique et Biologique 2009; 33(10-11): 911 doi: 10.1016/j.gcb.2009.06.001
|
| 10 |
Sahar Rostami, Hadi Parsian. Hyaluronic Acid: From Biochemical Characteristics to its Clinical Translation in Assessment of Liver Fibrosis. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.13787
|
| 11 |
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai‐Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius‐Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non‐invasive assessment of liver fibrosis in chronic viral hepatitis. European Journal of Clinical Investigation 2015; 45(12): 1243 doi: 10.1111/eci.12543
|
| 12 |
Susanne Beckebaum, Speranta Iacob, Christian G. Klein, Alexander Dechêne, Joye Varghese, Hideo A. Baba, Georgios C. Sotiropoulos, Andreas Paul, Guido Gerken, Vito R. Cicinnati. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients. Transplantation 2010; 89(8): 983 doi: 10.1097/TP.0b013e3181cc66ca
|
| 13 |
S. Harkisoen, J. E. Arends, A. van den Hoek, K. J. van Erpecum, G. J. Boland, A. I. M. Hoepelman. Low serum hyaluronic acid levels associated with spontaneous HBsAg clearance. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(11): 2183 doi: 10.1007/s10096-015-2467-x
|
| 14 |
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. Gene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
|
| 15 |
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
|
| 16 |
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Kyohei Kishino, Yoshihiro Shimono, Yoshiyuki Sakai, Takashi Nishimura, Nobuhiro Aizawa, Naoto Ikeda, Tomoyuki Takashima, Akio Ishii, Hiroko Iijima, Shuhei Nishiguchi. Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. Medicine 2016; 95(24): e3920 doi: 10.1097/MD.0000000000003920
|
| 17 |
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. cclm 2011; 49(1): 13 doi: 10.1515/CCLM.2011.001
|
| 18 |
JianPing Wu, WeiLin Mao. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/2471252
|
| 19 |
Madiha M. El-Attar, Hebat-Allah G. Rashed, Eman M. Sewify, Howayda E. Hassan. A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection. Arab Journal of Gastroenterology 2010; 11(4): 206 doi: 10.1016/j.ajg.2010.09.005
|
| 20 |
Simin Dokht Shoaei, Shahnaz Sali, Mehdi Karamipour, Esmail Riahi. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B. Hepatitis Monthly 2014; 14(2) doi: 10.5812/hepatmon.14228
|
| 21 |
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
|
| 22 |
Speranta Iacob, Vito Cicinnati, Iyad Kabar, Anna Hüsing-Kabar, Arnold Radtke, Razvan Iacob, Hideo Baba, Hartmut H. Schmidt, Andreas Paul, Susanne Beckebaum. Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkers. Transplant Immunology 2021; 69: 101448 doi: 10.1016/j.trim.2021.101448
|
| 23 |
Guangqin Xiao, Jiayin Yang, Lunan Yan. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis. Hepatology 2015; 61(1): 292 doi: 10.1002/hep.27382
|